title: Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.
abstract: Endovascular renal denervation techniques have been clinically adopted for the treatment of resistant arterial hypertension with great success. Despite the favourable early results achieved with this technology, a clear understanding of the pathophysiology underlying this novel treatment is lacking. In addition, non-responsiveness to renal denervation remains a nidus for treatment failure in distinct patients. In search of meaningful surrogate parameters relating to treatment responsiveness, the current article reviews the existing knowledge on renal nerve anatomy, changes occurring after denervation and procedural parameters collected during denervation. From preclinical experience, the most reliable morphological parameter reflecting successful renal denervation is the presence of axonal degeneration. Most procedural and clinical parameters need extended investigation before adopting them as potential surrogate parameters for successful renal denervation. As a consequence, there is an imperative need for dedicated research revealing the pathophysiology of renal denervation procedures. In this regard, close co-operation of engineers, researchers and clinicians is warranted to turn renal denervation into a milestone treatment of arterial hypertension.
authors.affiliation: Deutsches Herzzentrum und 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany.
authors.forename: Sonia
authors.initials: S
authors.lastname: Ammar
authors.forename: Elena
authors.initials: E
authors.lastname: Ladich
authors.forename: Kristin
authors.initials: K
authors.lastname: Steigerwald
authors.forename: Isabel
authors.initials: I
authors.lastname: Deisenhofer
authors.forename: Michael
authors.initials: M
authors.lastname: Joner
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D062186:Arterial Pressure / Q000187:drug effects; D017115:Catheter Ablation / Q000009:adverse effects / Q000295:instrumentation; D004351:Drug Resistance; D004867:Equipment Design; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D007668:Kidney / Q000294:innervation*; D013562:Sympathectomy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D013564:Sympathetic Nervous System / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D016896:Treatment Outcome; D062666:Vascular Access Devices
chemical_list: D000959:Antihypertensive Agents